Investors considering Monopar should keep a close eye out for announcements about further development of ALXN-1840. Any updates on its MNPR-101 line of oncology products, all of which are either in ...
Analysts at StockNews.com began coverage on shares of NantHealth (NASDAQ:NH – Get Free Report) in a research report issued on Wednesday. The firm set a “hold” rating on the stock. NantHealth Stock Up ...
Results that may be inaccessible to you are currently showing.